Scotts Miracle-Gro — Q1 FY2024 Form 10-Q
Reporting period: Three months ended December 30, 2023; unaudited. The company sells lawn and garden products and indoor/hydroponic gardening products. Results are seasonal: consumer sales are concentrated in the second and third fiscal quarters, so this first-quarter loss and cash use should be viewed in that context.
Key financial results
| Metric | Q1 FY2024 | Q1 FY2023 |
|---|---|---|
| Net sales | $410.4 million | $526.6 million |
| Gross margin | $62.2 million; 15.2% | $95.7 million; 18.2% |
| Loss from operations | $47.3 million | $41.8 million |
| Net loss | $80.5 million | $64.7 million |
| Diluted loss per share | $1.42 | $1.17 |
| Cash used in operating activities | $343.2 million | $431.6 million |
- Sales fell 22.1%, driven mainly by lower volume and mix (19.2 percentage points) and lower pricing (3.1 points); foreign exchange contributed 0.2 points.
- U.S. Consumer sales were $306.7 million, down 16.9%; Hawthorne sales were $80.1 million, down 39.1%; Other sales were $23.6 million, down 9.6%.
- Segment results weakened in U.S. Consumer (loss of $15.5 million versus profit of $31.3 million) and Other (loss of $5.0 million versus profit of $1.4 million). Hawthorne’s loss narrowed to $9.7 million from $16.2 million.
- SG&A declined 10.7% to $114.8 million. The gross margin rate decreased 3.0 percentage points; lower pricing, higher material and manufacturing costs, and weaker fixed-cost absorption outweighed benefits including lower restructuring charges.
Cash flow, debt and liquidity
- Operating cash outflow was $343.2 million; investing cash outflow was $53.2 million, including $37.9 million of capital spending and $21.4 million to acquire an additional 5% of Bonnie Plants. Financing provided $374.2 million, including $410.2 million of net debt borrowings for seasonal working capital needs.
- Cash was $10.4 million at quarter-end. Total debt was $3,043.5 million, up from $2,630.6 million at September 30, 2023 but below $3,427.3 million a year earlier. Revolving-credit availability was $660.7 million, with $78.0 million of letters of credit outstanding.
- Working capital included $1,169.6 million of inventory, up from $880.3 million at fiscal year-end. The company sold $199.6 million of receivables during the quarter under a new, uncommitted receivables purchase agreement; $140.1 million of receivables were derecognized at quarter-end.
- Shareholders’ equity was a deficit of $385.4 million, compared with a deficit of $267.3 million at September 30, 2023. The company declared dividends of $0.66 per share during the quarter.
Outlook, commentary and material items
- Management expects at least $300 million of annualized savings from its restructuring program, with nearly all expected by the end of fiscal 2024. Costs since inception through December 30, 2023 were $290.5 million; further restructuring charges may occur.
- Management expects cannabis-market oversupply to continue pressuring Hawthorne. It also cited persistent inflation, volatile commodity costs and higher interest rates, and expects targeted price reductions on certain products in fiscal 2024. The filing gives no specific full-year revenue or earnings guidance.
- The company reported a 7.20 leverage ratio versus a first-quarter covenant maximum of 8.25, and a fixed-charge coverage ratio of 1.08 versus a 0.75 minimum. It reported compliance with debt covenants and expects to remain compliant over the next 12 months, but cautioned that projections are uncertain. Covenant limits tighten over subsequent quarters.
- A default could accelerate credit-facility debt and trigger cross-defaults on senior notes; the company says it lacks sufficient cash or available liquidity to repay those amounts in that event. Contingency options include further cost reductions, lender amendments and financing that could include equity; success is not assured.
- Notable items included a $10.4 million pre-tax impairment of the Bonnie Plants investment, included in equity-method losses, and a $12.1 million gain from resolving a dispute with a former owner of a business acquired in fiscal 2022. Restructuring-related recoveries reduced reported expenses.
- Management said disclosure controls were effective at quarter-end; risk factors and market-risk disclosures had not materially changed from the prior annual report. Environmental liabilities recorded were $2.6 million; asbestos-related claims were not accrued because loss was not considered probable.
Most important facts for investors to verify
- Whether seasonal sales and cash generation in the second and third quarters support management’s covenant-compliance expectations as leverage limits decline.
- Progress on the $300 million annualized savings target, including remaining restructuring costs and whether savings improve margins.
- Hawthorne demand and inventory trends amid continued cannabis-market oversupply.
- Cash conversion, inventory levels and reliance on receivables sales and revolving-credit availability for seasonal funding.
- Interest expense and covenant headroom as borrowing rates remain elevated; any lender discussions or financing actions.